纳米体释放了新的机制,以准G蛋白结合受体
1Department of Biological Chemistry, University of Michigan School of Medicine, Ann Arbor, Michigan; Department of Pharmacology, University of Michigan School of Medicine, Ann Arbor, Michigan.
Molecular pharmacology
|March 8, 2026
概括
单域抗体 (纳米体) 现在是强大的G蛋白结合受体 (GPCR) 配体,具有独特的治疗潜力. 纳米体为新药开发提供了对GPCR信号通路的精确控制.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- G蛋白结合受体 (GPCRs) 是关键的药物点,但抗体疗法在很大程度上仍未被探索.
- 单域抗体或纳米体已经从结构工具演变为强大的GPCR配体.
研究的目的:
- 探索纳米体作为一种新型的G蛋白结合受体 (GPCR) 配体.
- 了解纳米体在调节GPCR信号传递中的分子机制和治疗潜力.
主要方法:
- 驼免疫和合成纳米体图书馆的开发.
- 用于纳米体发现和工程的计算设计平台.
- 关于纳米体-GPCR相互作用和功能结果的机制研究.
主要成果:
- 纳米体可以参与多种GPCR细胞外表因子,稳定独特的受体构造.
- 可以实现高选择性和新型药理学调制模式 (激动剂,对抗剂,逆激动剂,全调节剂).
- 工程纳米体 (双特异性,双价) 能够实现有针对性的治疗策略.
结论:
- 纳米体代表了针对GPCRs的有希望的抗体支架,扩大了超越小分子的治疗选择.
- 机械洞察力揭示了发展纳米体药理学和开发下一代GPCR治疗方法的策略.
- 纳米体在各种疾病背景下为调节GPCRs提供了一条新的途径.
相关概念视频
G Protein-coupled Receptors
18.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.6K
G-protein Coupled Receptors
133.3K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
133.3K
Transducer Mechanism: G Protein–Coupled Receptors
6.2K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
6.2K
Transducer Mechanism: Enzyme-Linked Receptors
4.6K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.6K
Activation and Inactivation of G Proteins
12.0K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
12.0K
GPCR Desensitization
8.5K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.5K


